文献速递其他结缔组织病

特发性炎症性肌病成人中PROMIS疼痛干扰、疲劳和身体功能作为患者报告结局的结构效度:OMERACT肌炎工作组的一项国际研究

Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group.
PubMed 文献 · Semin Arthritis Rheum · 2024-08-10

该国际研究纳入来自5个国家的135例成人特发性炎症性肌病(排除包涵体肌炎)患者,评估PROMIS疼痛干扰、疲劳和身体功能简表与核心疾病活动度指标的结构效度。预设相关性假设分别有83%、80%和75%得到验证,各量表内部一致性高(Cronbach's alpha >0.9),仅疼痛干扰存在天花板效应(29%患者无/低疼痛)。作者认为这些PROMIS量表结构效度强,支持用于评估疾病生活影响。

要点

  • 预设假设验证率:疼痛干扰5/6(83%)、疲劳4/5(80%)、身体功能3/4(75%)。
  • 各PROMIS量表内部一致性高(Cronbach's alpha >0.9)。
  • 仅疼痛干扰出现天花板效应,29%患者报告无/低疼痛。

核心结论

  • PROMIS疼痛干扰6a、疲劳7a和身体功能8b简表与核心疾病活动度指标相比显示强结构效度,且在皮肌炎与非皮肌炎IIM亚型间结果一致。
  • 作者认为这些发现支持使用所选PROMIS量表评估IIM中生活影响的核心关注域。

研究设计与样本

  • 国际多中心研究,纳入来自北美、欧洲、亚洲和澳大利亚5个国家的135例成人特发性炎症性肌病(排除包涵体肌炎)患者。
  • 患者完成PROMIS疼痛干扰6a、疲劳7a和身体功能8b简表,同时评估患者和医生全局疾病活动度、徒手肌力测试、血清肌酸激酶活性和HAQ-DI。
  • 由OMERACT肌炎工作组成员以>70%同意率预设PROMIS量表与年龄及核心疾病指标预期相关性的假设,并与观察到的Pearson相关性比较。
  • 评估各量表条目的内部一致性及地板/天花板效应,并按IIM亚型(皮肌炎 vs 非皮肌炎)进行亚组分析。

主要发现

  • 结构效度方面,预设假设在疼痛干扰中验证5/6(83%)、疲劳中4/5(80%)、身体功能中3/4(75%)。
  • 各PROMIS量表内部一致性高(Cronbach's alpha >0.9)。
  • 天花板效应仅见于PROMIS疼痛干扰,29%患者报告无/低疼痛。
  • 皮肌炎(n=65)与非皮肌炎(n=70)亚组间,PROMIS量表与疾病活动度指标的相关性相似。

关键数值与推荐

  • 预设假设验证率:疼痛干扰5/6(83%)、疲劳4/5(80%)、身体功能3/4(75%)。
  • 内部一致性:各PROMIS量表Cronbach's alpha >0.9。
  • 天花板效应:PROMIS疼痛干扰中29%患者无/低疼痛。
  • 亚组样本量:皮肌炎n=65,非皮肌炎n=70。

临床怎么用

  • 作者认为这些发现支持使用所选PROMIS疼痛干扰6a、疲劳7a和身体功能8b简表评估IIM中生活影响的核心关注域。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Validated patient-reported outcome measures to assess disease impact in patients with adult idiopathic inflammatory myopathies (IIMs) are needed. The objective of this study was to assess the construct validity of PROMIS Pain Interference, Fatigue, and Physical Function measures in comparison with core disease activity measures. METHODS: Adults with IIM, excluding inclusion body myositis, from OMERACT Myositis Working Group (MWG) clinic sites completed PROMIS Short Form v1.0-Pain Interference 6a, PROMIS Short Form v1.0-Fatigue 7a, and PROMIS Short Form v2.0-Physical Function 8b measures. Core disease activity measures including patient and physician global disease activity assessments, manual muscle testing, serum creatine kinase activity, and Health Assessment Questionnaire Disability Index (HAQ-DI) were simultaneously assessed. To evaluate construct validity, a priori hypotheses for the expected correlations between PROMIS measures, age, and core disease measures were determined by >70 % agreement among MWG members and were compared against observed Pearson's correlations. Internal consistency of items and floor or ceiling effects for the PROMIS measures were also assessed. Subgroup analysis according to IIM subtype (dermatomyositis vs. non-dermatomyositis IIM) was performed. RESULTS: 135 adults with IIM from 5 countries across North America, Europe, Asia, and Australia were included. For construct validity, a priori hypotheses were confirmed for 5 of 6 (83 %) PROMIS Pain Interference, 4 of 5 (80 %) PROMIS Fatigue, and 3 of 4 (75 %) PROMIS Physical Function correlations. Internal consistency was high for each PROMIS measure (Cronbach's alpha >0.9). Ceiling effects were observed only for PROMIS Pain Interference, with low/no pain in 29 % of patients. Subgroup analysis between dermatomyositis (n = 65) and non-dermatomyositis (n = 70) subtypes demonstrated similar correlations between PROMIS measures and disease activity measures. CONCLUSIONS: PROMIS Short Form v1.0-Pain Interference 6a, PROMIS Short Form v1.0-Fatigue 7a, and PROMIS Short Form v2.0-Physical Function 8b measures demonstrate strong construct validity when compared to core disease activity measures in IIM, with consistent results across IIM subtypes. These findings support the use of these selected PROMIS measures to assess core domains of interest for measuring life impact in IIMs.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Romich E, Saygin D, DiRenzo D, et al. Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group. Semin Arthritis Rheum. 2024. PMID: 39159576. doi:10.1016/j.semarthrit.2024.152534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。